565 related articles for article (PubMed ID: 21084751)
1. Salt-inducible kinase 2 links transcriptional coactivator p300 phosphorylation to the prevention of ChREBP-dependent hepatic steatosis in mice.
Bricambert J; Miranda J; Benhamed F; Girard J; Postic C; Dentin R
J Clin Invest; 2010 Dec; 120(12):4316-31. PubMed ID: 21084751
[TBL] [Abstract][Full Text] [Related]
2. The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans.
Benhamed F; Denechaud PD; Lemoine M; Robichon C; Moldes M; Bertrand-Michel J; Ratziu V; Serfaty L; Housset C; Capeau J; Girard J; Guillou H; Postic C
J Clin Invest; 2012 Jun; 122(6):2176-94. PubMed ID: 22546860
[TBL] [Abstract][Full Text] [Related]
3. Farnesoid X receptor inhibits the transcriptional activity of carbohydrate response element binding protein in human hepatocytes.
Caron S; Huaman Samanez C; Dehondt H; Ploton M; Briand O; Lien F; Dorchies E; Dumont J; Postic C; Cariou B; Lefebvre P; Staels B
Mol Cell Biol; 2013 Jun; 33(11):2202-11. PubMed ID: 23530060
[TBL] [Abstract][Full Text] [Related]
4. O-GlcNAcylation increases ChREBP protein content and transcriptional activity in the liver.
Guinez C; Filhoulaud G; Rayah-Benhamed F; Marmier S; Dubuquoy C; Dentin R; Moldes M; Burnol AF; Yang X; Lefebvre T; Girard J; Postic C
Diabetes; 2011 May; 60(5):1399-413. PubMed ID: 21471514
[TBL] [Abstract][Full Text] [Related]
5. Polyunsaturated fatty acids suppress glycolytic and lipogenic genes through the inhibition of ChREBP nuclear protein translocation.
Dentin R; Benhamed F; Pégorier JP; Foufelle F; Viollet B; Vaulont S; Girard J; Postic C
J Clin Invest; 2005 Oct; 115(10):2843-54. PubMed ID: 16184193
[TBL] [Abstract][Full Text] [Related]
6. Hepatic glucokinase is required for the synergistic action of ChREBP and SREBP-1c on glycolytic and lipogenic gene expression.
Dentin R; Pégorier JP; Benhamed F; Foufelle F; Ferré P; Fauveau V; Magnuson MA; Girard J; Postic C
J Biol Chem; 2004 May; 279(19):20314-26. PubMed ID: 14985368
[TBL] [Abstract][Full Text] [Related]
7. ChREBP regulates fructose-induced glucose production independently of insulin signaling.
Kim MS; Krawczyk SA; Doridot L; Fowler AJ; Wang JX; Trauger SA; Noh HL; Kang HJ; Meissen JK; Blatnik M; Kim JK; Lai M; Herman MA
J Clin Invest; 2016 Nov; 126(11):4372-4386. PubMed ID: 27669460
[TBL] [Abstract][Full Text] [Related]
8. Deletion of hepatic carbohydrate response element binding protein (ChREBP) impairs glucose homeostasis and hepatic insulin sensitivity in mice.
Jois T; Chen W; Howard V; Harvey R; Youngs K; Thalmann C; Saha P; Chan L; Cowley MA; Sleeman MW
Mol Metab; 2017 Nov; 6(11):1381-1394. PubMed ID: 29107286
[TBL] [Abstract][Full Text] [Related]
9. Hepatic Carbohydrate Response Element Binding Protein Activation Limits Nonalcoholic Fatty Liver Disease Development in a Mouse Model for Glycogen Storage Disease Type 1a.
Lei Y; Hoogerland JA; Bloks VW; Bos T; Bleeker A; Wolters H; Wolters JC; Hijmans BS; van Dijk TH; Thomas R; van Weeghel M; Mithieux G; Houtkooper RH; de Bruin A; Rajas F; Kuipers F; Oosterveer MH
Hepatology; 2020 Nov; 72(5):1638-1653. PubMed ID: 32083759
[TBL] [Abstract][Full Text] [Related]
10. Lack of liver glycogen causes hepatic insulin resistance and steatosis in mice.
Irimia JM; Meyer CM; Segvich DM; Surendran S; DePaoli-Roach AA; Morral N; Roach PJ
J Biol Chem; 2017 Jun; 292(25):10455-10464. PubMed ID: 28483921
[TBL] [Abstract][Full Text] [Related]
11. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.
Dentin R; Benhamed F; Hainault I; Fauveau V; Foufelle F; Dyck JR; Girard J; Postic C
Diabetes; 2006 Aug; 55(8):2159-70. PubMed ID: 16873678
[TBL] [Abstract][Full Text] [Related]
12. Mechanism for fatty acid "sparing" effect on glucose-induced transcription: regulation of carbohydrate-responsive element-binding protein by AMP-activated protein kinase.
Kawaguchi T; Osatomi K; Yamashita H; Kabashima T; Uyeda K
J Biol Chem; 2002 Feb; 277(6):3829-35. PubMed ID: 11724780
[TBL] [Abstract][Full Text] [Related]
13. Regulation of rat hepatic L-pyruvate kinase promoter composition and activity by glucose, n-3 polyunsaturated fatty acids, and peroxisome proliferator-activated receptor-alpha agonist.
Xu J; Christian B; Jump DB
J Biol Chem; 2006 Jul; 281(27):18351-62. PubMed ID: 16644726
[TBL] [Abstract][Full Text] [Related]
14. Targeting hepatic pyruvate dehydrogenase kinases restores insulin signaling and mitigates ChREBP-mediated lipogenesis in diet-induced obese mice.
Wu CY; Tso SC; Chuang JL; Gui WJ; Lou M; Sharma G; Khemtong C; Qi X; Wynn RM; Chuang DT
Mol Metab; 2018 Jun; 12():12-24. PubMed ID: 29656110
[TBL] [Abstract][Full Text] [Related]
15. Leptin ameliorates insulin resistance and hepatic steatosis in Agpat2-/- lipodystrophic mice independent of hepatocyte leptin receptors.
Cortés VA; Cautivo KM; Rong S; Garg A; Horton JD; Agarwal AK
J Lipid Res; 2014 Feb; 55(2):276-88. PubMed ID: 24293639
[TBL] [Abstract][Full Text] [Related]
16. Histone modifications in FASN modulated by sterol regulatory element-binding protein 1c and carbohydrate responsive-element binding protein under insulin stimulation are related to NAFLD.
Du X; Cai C; Yao J; Zhou Y; Yu H; Shen W
Biochem Biophys Res Commun; 2017 Jan; 483(1):409-417. PubMed ID: 28027934
[TBL] [Abstract][Full Text] [Related]
17. Distinct regulation of adiponutrin/PNPLA3 gene expression by the transcription factors ChREBP and SREBP1c in mouse and human hepatocytes.
Dubuquoy C; Robichon C; Lasnier F; Langlois C; Dugail I; Foufelle F; Girard J; Burnol AF; Postic C; Moldes M
J Hepatol; 2011 Jul; 55(1):145-53. PubMed ID: 21145868
[TBL] [Abstract][Full Text] [Related]
18. Carbohydrate response element binding protein directly promotes lipogenic enzyme gene transcription.
Ishii S; Iizuka K; Miller BC; Uyeda K
Proc Natl Acad Sci U S A; 2004 Nov; 101(44):15597-602. PubMed ID: 15496471
[TBL] [Abstract][Full Text] [Related]
19. Role of ChREBP in hepatic steatosis and insulin resistance.
Denechaud PD; Dentin R; Girard J; Postic C
FEBS Lett; 2008 Jan; 582(1):68-73. PubMed ID: 17716660
[TBL] [Abstract][Full Text] [Related]
20. [Can the hyperactivity of lipogenesis cause hepatic steatosis? A role for ChREBP].
Robichon C; Girard J; Postic C
Med Sci (Paris); 2008 Oct; 24(10):841-6. PubMed ID: 18950580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
